Related Experiment Video
Updated: Jun 19, 2026

12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
STUDIES OF THE TRANSMISSIBLE AGENT OF THE ROUS CHICKEN SARCOMA I : PRECIPITATION WITH BASIC PROTEINS
D Shemin1, E E Sproul, J W Jobling
1Department of Pathology, College of Physicians and Surgeons, Columbia University, New York.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Polysaccharide enzymes from pneumococcus or testis reduce Rous sarcoma extract viscosity, allowing for concentrated active agent recovery. Basic proteins precipitate the active agent, which is then purified using electrophoresis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Rous sarcoma virus (RSV) is an oncogenic retrovirus.
- RSV extracts possess high viscosity, hindering purification and concentration of the active transforming agent.
- Efficient isolation of the RSV active agent is crucial for understanding viral oncogenesis.
Purpose of the Study:
- To develop a method for reducing the viscosity of Rous sarcoma extracts.
- To enable higher concentrations of the active transforming agent.
- To facilitate the purification of the active agent from tumor filtrate components.
Main Methods:
- Treatment of Rous sarcoma extracts with polysaccharide enzymes from *Pneumococcus* or testis.
- Precipitation of the active agent using basic proteins.
- Separation of the precipitated active agent from other filtrate components via electrophoresis.
Main Results:
- Viscosity reduction achieved using polysaccharide enzymes without inactivating the active agent.
- Successful precipitation and isolation of the active agent using basic proteins.
- Electrophoresis effectively separated the active agent from contaminating substances.
Conclusions:
- Polysaccharide enzymes offer a non-destructive method to decrease extract viscosity.
- Basic protein precipitation is a viable strategy for concentrating the active agent.
- Electrophoresis provides a means for purifying the concentrated active agent from Rous sarcoma extracts.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

